Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method and application of medical carbonate nano material

A nanomaterial and carbonate technology, applied in the field of biomedical nanomaterials, can solve problems such as limiting the development of nanomaterials, and achieve the effect of inducing apoptosis and necrosis

Active Publication Date: 2021-04-06
XIAMEN UNIV
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Inorganic nanomaterials have the advantages of simple synthesis, large-scale production, and easy quality control, but the safety and health factors in clinical transformation limit the further development of nanomaterials, especially the in vivo degradation of inorganic nanomaterials is an urgent problem to be solved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of medical carbonate nano material
  • Preparation method and application of medical carbonate nano material
  • Preparation method and application of medical carbonate nano material

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] Synthesis and characterization of embodiment 1 manganese carbonate nanoparticles

[0074] (1) Manganese chloride tetrahydrate and indocyanine green were mixed and stirred for 3 hours according to the mass ratio of 50:1-50:3;

[0075] (2) Place the material (Mn-ICG) gained in step (1) in ammonium bicarbonate (NH 3 HCO 3 ) in an environment of decomposition and diffusion, react at room temperature (30°C), and the reaction time can be controlled within 1-4h;

[0076] (3) The material obtained in step (2) is centrifuged at 5000rpm for 10min, and the precipitate is taken;

[0077] (4) ultrasonically disperse the precipitate obtained in step (3) in 20 mL of absolute ethanol, centrifuge and wash at 5000 rpm for 10 min, repeat this step 3 times, and obtain the precipitate;

[0078] (5) Disperse the precipitate obtained in step (4) in 50 mL of absolute ethanol, and add polyallylamine hydrochloride (PAH, molecular formula (C 3 h 7 N) n xHCl, the average molecular weight is ...

Embodiment 2

[0084] Example 2MnCO 3 -ICG nanomaterials for cell experiments

[0085] Taking murine breast cancer 4T1 cells as a research model, the MnCO prepared in Example 1 was further explored. 3 - Research on ICG nanomaterials for combination therapy of tumors. At the same time, human malignant glioma U87MG cells and human liver cancer HepG2 cells were used to verify MnCO 3 -Therapeutic effect of ICG nanomaterials on tumor cells.

[0086] (1) Cell uptake test

[0087] Seed 4T1 cells on glass bottom cell culture dish (confocal dish) Medium (10 5 cells), cultured for 24h, after the cells adhered to the wall, mixed with MnCO 3 -ICG medium ([Mn]: 5μg / mL) was co-incubated for different times (2, 4, 8, 12 and 24h), washed three times with PBS, stained with Hoechst33342 (5μg / mL) for nuclei, washed three times, supplemented For fresh culture medium, use Olympus FV1200 laser confocal microscope to detect the fluorescence of ICG to judge the uptake of materials by cells. Such as Figur...

Embodiment 3

[0108] Example 3MnCO 3 -ICG nanomaterials used in animal experiments

[0109] Experimental animal model: female BALB / c mice (body weight 16-18 g) were purchased from the Shanghai Slack Experimental Animal Center by the Experimental Animal Center of Xiamen University.

[0110] Tumor model: by subcutaneous injection of 100 μL of 4T1 cells (2×10 6 ) in the right hind leg of the experimental mice, inoculated subcutaneously with 4T1 tumors.

[0111] All animal experiments were in accordance with the animal protection regulations approved by the Experimental Animal Use Committee and Experimental Animal Ethics Committee of Xiamen University.

[0112] (1)MnCO 3 -Study on the distribution and metabolic behavior of ICG nanomaterials in vivo

[0113] A. Female BALB / c mice bearing 4T1 tumors when the tumor reaches 80-100mm 3 Intravenous injection of MnCO 3 - ICG nanomaterials ([Mn]: 2mg / kg) (n=3), at different time points (0.5, 1, 2, 4, 8, 12, 24, 48h) after drug injection, blood sa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Longitudinal relaxation rateaaaaaaaaaa
Half inhibitory concentrationaaaaaaaaaa
Longitudinal relaxation rateaaaaaaaaaa
Login to View More

Abstract

The invention discloses a preparation method and application of a medical carbonate nano material. The method comprises the following steps: mixing divalent metal ions with medical organic functional molecules capable of coordinating with the divalent metal ions, performing reacting in an ammonium bicarbonate dispersion and diffusion environment at room temperature, and performing reacting with polyallylamine hydrochloride to obtain the medical carbonate nano material. The divalent metal ion is Mn(II) or Ca(II), and the medical organic functional molecule is indocyanine green or dexamethasone sodium phosphate.

Description

technical field [0001] The invention belongs to the technical field of biomedical nanomaterials, and in particular relates to a preparation method and application of medical carbonate nanomaterials. Background technique [0002] Cancer is still one of the important causes of global threats to human health, and cancer treatment remains a daunting challenge. At present, traditional clinical treatment methods commonly used include surgery, radiotherapy, chemotherapy, etc. These methods can cure local tumors and prolong the survival of patients, but they cannot inhibit tumor recurrence and metastasis. The combination of nanotechnology and modern biology and medicine provides more opportunities for the treatment of tumors. Inorganic nanomaterials have the advantages of simple synthesis, large-scale production, and easy quality control, but the safety and health factors in clinical transformation limit the further development of nanomaterials, especially the in vivo degradation o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K49/00A61K49/08A61K31/573A61K41/00A61K47/32A61P35/00B82Y5/00
CPCA61K49/0002A61K31/573A61K49/0034A61K49/08A61K41/0052A61K47/32A61P35/00B82Y5/00A61K2300/00
Inventor 陈洪敏冯宇硕孙文静
Owner XIAMEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com